Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity

被引:0
|
作者
A Sayadi
J Jeyakani
S H Seet
C-L Wei
G Bourque
F A Bard
N A Jenkins
N G Copeland
E A Bard-Chapeau
机构
[1] Institute of Molecular and Cell Biology,
[2] Genome Institute of Singapore,undefined
[3] 3Current address: The Methodist Hospital Research Institute,undefined
[4] Houston,undefined
[5] TX,undefined
[6] USA.,undefined
[7] 4Current address: Novartis Institutes for Biomedical Researtch,undefined
[8] WKL-125.1.05A,undefined
[9] Basel CH-4002,undefined
[10] Switzerland.,undefined
来源
Oncogene | 2016年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The MDS1 and ecotropic viral integration site 1 (EVI1) complex locus (MECOM) gene encodes several transcription factor variants including MDS1-EVI1, EVI1 and EVI1Δ324. Although MDS1-EVI1 has been associated with tumor-suppressing activity, EVI1 is a known oncogene in various cancers, whose expression is associated with poor patient survival. Although EVI1Δ324 is co-transcribed with EVI1, its activity in cancer cells is not fully understood. Previous reports described that unlike EVI1, EVI1Δ324 protein cannot transform fibroblasts because of its disrupted N-terminal zinc finger (ZNF) domain. To better understand EVI1Δ324 biology and function, we obtained genome-wide binding occupancies and expression data in ovarian cancer cells. We characterized its DNA-binding sites, binding motif and target genes. Comparative analyses with previous study show that EVI1 and EVI1Δ324 share similar transcriptional activities linked to their common C-terminus ZNF domain. They bind to an E-twenty-six family (ETS)-like motif, target to a large extent the same genes and cooperate with AP1 transcription factor. EVI1Δ324-occupied genes were 70.7% similar to EVI1-bound genes. More strikingly, EVI1 and EVI1Δ324 differentially expressed genes were 99.87% identical, indicating comparable transcriptional regulatory functions. Consistently with gene ontologies linked to these target genes, EVI1Δ324 expression in HeLa cells could enhance anchorage-independent growth, such as EVI1, showing that EVI1Δ324 expression also lead to pro-oncogenic effects. The main specific feature of EVI1 variant is its N-terminus ZNF domain that binds DNA through GATA-like motif. We found that most GATA-like EVI1 chromatin immunoprecipitation sequencing peaks are far from genes and are not involved in transcriptional regulation. These genomic regions were enriched in simple sequence repeats and displayed high meiotic recombination rates. Overall, our genomics analyses uncovered common and specific features of two major MECOM isoforms. Their influence on transcription and downstream cell proliferation was comparable. However, EVI1-specific GATA-like binding sites, from its N-terminus ZNF domain, associated with high recombination rates, suggesting possible additional oncogenic potential for EVI1 in modulating genomic stability.
引用
收藏
页码:2311 / 2321
页数:10
相关论文
共 50 条
  • [21] Identification of ZFP91 As the Master Transcription Factor for EVI1 Gene Expression
    Hayashida, Hiroki
    Hino, Toshiya
    Morita, Ken
    Masamoto, Yosuke
    Kurokawa, Mineo
    [J]. BLOOD, 2023, 142
  • [22] THE EVI1 TRANSCRIPTION FACTOR REPRESSES ITS OWN TRANSCRIPTION IN HUMAN CELLS
    Maicas, M.
    Vazquez, I.
    Garcia-Sanchez, M. A.
    Marcotegui, N.
    Ciraqui, C.
    Guruceaga, E.
    Alonso, M.
    Conchillo, A.
    Odero, M. D.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 34 - 34
  • [23] EVI1 isoforms exhibit different effects on growth and apoptosis in ovarian cancer
    Ferriss, J. S.
    Machida, Y.
    Dalton, S.
    Bryant, J.
    Dutta, A.
    Jazaeri, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S133 - S134
  • [24] The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase
    Vinatzer, U
    Taplick, J
    Seiser, C
    Fonatsch, C
    Wieser, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) : 566 - 573
  • [25] EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription
    Edward Ayoub
    Michael P. Wilson
    Kathleen E. McGrath
    Allison J. Li
    Benjamin J. Frisch
    James Palis
    Laura M. Calvi
    Yi Zhang
    Archibald S. Perkins
    [J]. Nature Communications, 9
  • [26] EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription
    Ayoub, Edward
    Wilson, Michael P.
    McGrath, Kathleen E.
    Li, Allison J.
    Frisch, Benjamin J.
    Palis, James
    Calvi, Laura M.
    Zhang, Yi
    Perkins, Archibald S.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [27] CHARACTERIZATION OF THE TRANSLOCATIONS AND INVERSIONS ASSOCIATED WITH ACTIVATION OF THE EVI1 GENE IN AML
    JAGASIA, S
    PARGANAS, E
    GAJJAR, A
    IHLE, JN
    [J]. BLOOD, 1994, 84 (10) : A230 - A230
  • [28] Clinical Features and Early Effect in EVI1 Positive Acute Myeloid Lleukemia
    Duan, Wenbing
    Gong, Lizhong
    Jia, Jinsong
    Zhu, Honghu
    Zhao, Xiaosu
    Jiang, Qian
    Zhao, Ting
    Qin, Ya-Zhen
    Huang, Xiaojun
    Jiang, Hao
    [J]. BLOOD, 2017, 130
  • [29] EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells
    De Weer, An
    Van der Meulen, Joni
    Rondou, Pieter
    Taghon, Tom
    Konrad, Torsten A.
    De Preter, Katleen
    Mestdagh, Pieter
    Van Maerken, Tom
    Van Roy, Nadine
    Jeison, Marta
    Yaniv, Isaac
    Cauwelier, Barbara
    Noens, Lucien
    Poirel, Helene-Antoine
    Vandenberghe, Peter
    Lambert, Frederic
    De Paepe, Anne
    Sanchez, Maria Garcia
    Odero, Maria
    Verhasselt, Bruno
    Philippe, Jan
    Vandesompele, Joke
    Wieser, Rotraud
    Dastugue, Nicole
    Van Vlierberghe, Pieter
    Poppe, Bruce
    Speleman, Frank
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (03) : 337 - 348
  • [30] REGULATION OF CHRONIC MYELOID LEUKEMIA STEM CELLS BY LEUKEMIA ONCOGENE EVI1
    Sato, T.
    Goyama, S.
    Kataoka, K.
    Tsuruta, T.
    Nasu, R.
    Nakagawa, M.
    Kumano, K.
    Kurokawa, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 452 - 452